Lesson plan
NAS-181
NAS-181, also known as MCOMM, is a selective rodent serotonin 5-HT 1B receptor antagonist which is used in scientific research. In animals, NAS-181 has been found to strongly increase acetylcholine levels in the frontal cortex and hippocampus. It has been found to block memory impairment induced by the antimuscarinic agent scopolamine and by the NMDA receptor antagonist dizocilpine (MK-801). Injection of NAS-181 directly into the nucleus accumbens has also been found to reverse the prosocial behavior induced by the serotonin releasing agent MDMA in animals. NAS-181 was first described in the scientific literature by 1998. The drug was discovered by researchers at Astra Arcus.
Article summary
NAS-181, also known as MCOMM, is a selective rodent serotonin 5-HT 1B receptor antagonist which is used in scientific research. In animals, NAS-181 has been found to strongly increase acetylcholine levels in the frontal cortex and hippocampus. It has been found to block memory impairment induced by the antimuscarinic agent scopolamine and by the NMDA receptor antagonist dizocilpine (MK-801). Injection of NAS-181 directly into the nucleus accumbens has also been found to reverse the prosocial behavior induced by the serotonin releasing agent MDMA in animals. NAS-181 was first described in the scientific literature by 1998. The drug was discovered by researchers at Astra Arcus.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.